Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice

Journal of Urology

Volumn 160, Issue 4, 1998, Pages 1500-1505

  Hsu, Chun X ^b   Ross, Brian D ^b   Chrisp, Clarence E ^b   Derrow, Solomon Z ^b   Charles, Linda G ^b   Pienta, Kenneth J ^b   Greenberg, Norman M ^b   Zeng, Zhi ^b   Sanda, Martin G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

MRI; Prostate cancer; SV40 T antigen; Transgenic mice; Tumor volume

Indexed keywords

DNA; VIRUS T ANTIGEN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; TRANSGENIC MOUSE; TUMOR VOLUME;

EID: 0032322495     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62603-X     Document Type: Article

References (31)

1. Parker, S. L., Tong, T., Bolden, S., Wingo, P. A.: Cancer statistics. CA: A Cancer J. Clin., 46: 5, 1997.
2. Walsh, P. C.: Prostate cancer kills: a strategy to reduce deaths. Urology, 44: 463, 1994.
3. Pollard, M.: The Lobound-Wistar rat model of prostate cancer. J. Cell Biochem., 16H(Suppl.): 84, 1992.
4. Ward, J. M., Reznik, G., Stinson, S. F., Lattuada, C. P., Longfellow, D. G. and Cameron, T. P.: Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/ segHapBR rat. Lab Invest., 43: 517, 1980.
5. Shirai, T., Tamano, S., Kato, T., Iwasaki, S., Takahashi, S. and Ito, N.: Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate or rats given 3,2′dimethyl-4aminobiphenyl and testosterone propionate. Cancer Res., 51: 1264, 1991.
6. Pour, P. M. and Stepan, K.: Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobin (2-oxoprophyl)-amine. Cancer Res., 47: 5699, 1987.
7. Bosland, M. C.: Animal models for the study of prostate carcino-genesis. J. Cell Biochem., 16H: 89, 1992.
8. Nobel, R. L.: Development of androgen-stimulated transplants of Nb rat carcinoma of the dorsal prostate and their response to sex hormones and tamoxifen. Cancer Res., 40: 3551, 1980.
9. Royai, R., Lange, P. H. and Vessella, R.: Pre-clinical models of prostate cancer. Semin. Oncol., 23: 35, 1996.
10. Isaacs, J. and Coffey, D.: Model systems for the study of prostatic cancer. Clin. Oncol., 2: 479, 1983.
11. Thompson, T. C., Park, S. H., Timme, T. L., Ren, C., Eastham, J. A. and Donehower, L. A.: Loss of p53 function lead to metastasis in ras + myc-inituated mouse prostate cancer. Oncogene, 10: 869, 1995.
12. Buttyan, R. and Slawin, K.: Rodent models for targeted oncogenesis of the prostate gland. Cancer Metastasis Rev., 12: 11, 1993.
13. Maroulakou, I., Anver, M., Garrett, L. and Green, J.: Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Science USA, 91: 11236, 1994.
14. Perez-Stable, C.: Distinct Negative regulatory mechanisms involved in the repression of human embryonic ∈- and fetal Gγ-globin genes in transgenic mice. J. Biol. Chem., 269: 33109, 1994.
15. Greenberg, N., DeMayo, F., Finegold, M., Medina, D., Tilley, W. and Aspinall, J.: Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA, 92: 3439, 1995.
16. Shibata, M., Ward, J. M., Devor, D. E., Liu, M. and Green, J. E.: Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large 7 antigen transgenic mice: histopathological and molecular biological alterations. Cancer Res., 56: 4894, 1996.
17. Chada, K., Magram, J. and Costantini, F.: An embryonic pattern of expression of a human fetal globin gene in transgenic mice. Nature, 319: 685, 1986.
18. Perez-Stable, C., Altman, N., Mehta, P., Deftos, L. and Roos, B.: Prostate cancer progression, metastasis, and gene expression in transgenic mice. Cancer Res., 57: 900, 1997.
19. Dodd, J. G., Sheppard, P. C. and Matusik, R. J.: Characterization and cloning of rat dorsal prostate mRNAs. J. Biol. Chem., 258: 10731, 1983.
20. Gingrich, J., Barrios, R., Morton, R., Boyce, B., DeMayo, F. and Finegold, M.: Metastatic prostate cancer in a transgenic mouse. Cancer Res., 56: 4096, 1996.
21. Greenberg, N. M., DeMayo, F. J., Sheppard, P. C., Barrios, R., Lebovitz, R. and Finegold, M.: The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol., 8: 230, 1994.
22. Miller, S. A., Dykes, D. D. and Polesky, H. F.: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16: 1215, 1988.
23. McCarthy, S. A., Symond, H. S. and Van Dyke, T.: Regulation of apoptosis in transgenic mice by SV40 T antigen-mediated inactivation of p53. Proc. Natl. Acad. Science USA, 91: 3979, 1994.
24. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S. and Jacks, T.: p53-Dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703, 1994.
25. Matusik, R. J., Kreis, C., McNicol, P., Sweetland, R., Mullin, C. and Fleming, W. H.: Regulation of prostatic genes: Roles of androgens and zinc in expression. J. Biochem. Cell Biol., 64: 601, 1986.
26. Alexander, A. A., Liu, J., McCue, P., Gomella, L. G., Ross, R. P. and Lattime, E. C.: Intravesical growth of murine bladder tumors assessed by transrectal ultrasound. J. Urol., 150: 525, 1993.
27. Chin, J., Kadhim, S., Garcia, B., Kim, Y. S. and Karlik, S.: Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants. J. Urol., 145: 1297, 1991.
28. Mahmood, U., Devitt, M. L., Kocheril, P. G., Sutanto-Ward, E., Ballon, D. and Sigurdson, E. R.: Quantitation of total metastatic tumor volume in rat liver: correlation of MR and histologic measurements. J. Mag. Res. Imaging, 2: 335, 1992.
29. Rajan, S. S., Rosa, L., Francisco, J., Muraki, A., Carvlin, M. and Tuturea, E.: MRI characterization of 9L-glioma in rat brain at 4.7 tesla. Magnetic Resonance Imaging, 8: 195, 1990.
30. Quin, Y., Cauteren, M. V., Osteaux, M., Schally, A. V. and Willems, G.: Inhibitory effects of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging. Cancer Res., 52: 6025, 1992.
31. Kim, B., Chenevert, T. L. and Ross, B.: Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. Clin. Cancer Res., 1: 643, 1995.